Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segment elevation acute coronary syndrome patients

Pedro Beraldo de Andrade, Luiz Alberto Piva E Mattos, Marden André Tebet, Fábio Salerno Rinaldi, Vinícius Cardozo Esteves, Ederlon Ferreira Nogueira, João Ítalo Dias França, Mônica Vieira Athanazio de Andrade, Robson Alves Barbosa, André Labrunie, Alexandre Antônio Cunha Abizaid, Amanda Guerra de Moraes Rego Sousa, Pedro Beraldo de Andrade, Luiz Alberto Piva E Mattos, Marden André Tebet, Fábio Salerno Rinaldi, Vinícius Cardozo Esteves, Ederlon Ferreira Nogueira, João Ítalo Dias França, Mônica Vieira Athanazio de Andrade, Robson Alves Barbosa, André Labrunie, Alexandre Antônio Cunha Abizaid, Amanda Guerra de Moraes Rego Sousa

Abstract

Background: Arterial access is a major site of bleeding complications after invasive coronary procedures. Among strategies to decrease vascular complications, the radial approach is an established one. Vascular closure devices provide more comfort to patients and decrease hemostasis and need for bed rest. However, the inconsistency of data proving their safety limits their routine adoption as a strategy to prevent vascular complications, requiring evidence through adequately designed randomized trials. The aim of this study is to compare the radial versus femoral approach using a vascular closure device for the incidence of arterial puncture site vascular complications among non-ST-segment elevation acute coronary syndrome patients submitted to an early invasive strategy.

Methods: ARISE is a national, multicenter, non-inferiority randomized clinical trial. Two hundred patients with non-ST-segment elevation acute coronary syndrome will be randomized to either radial or femoral access using a vascular closure device. The primary outcome is the occurrence of vascular complications at an arterial puncture site 30 days after the procedure, including major bleeding, retroperitoneal hematoma, compartment syndrome, hematoma ≥ 5 cm, pseudoaneurysm, arterio-venous fistula, infection, limb ischemia, arterial occlusion, adjacent nerve injury or the need for vascular surgical repair.

Results: Enrollment was initiated in September 2012, and until October 2013 91 patients were included. The inclusion phase is expected to last until the second half of 2014.

Conclusions: The ARISE trial will help define the role of a vascular closure device as a bleeding avoidance strategy in patients with NSTEACS.

Trial registration: ClinicalTrials.gov identifier: NCT01653587.

Figures

Figure 1
Figure 1
ARISE study design: a randomized trial of the radial versus femoral approach using AngioSeal in non-ST-segment elevation acute coronary syndrome (NSTEACS) patients.

References

    1. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H. et al.ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology. Eur Heart J. 2011;14:2999–3054.
    1. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr. et al.ACCF/AHA focused update incorporated into the guideline for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2012;14(61):e179–e347.
    1. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;14:494–502.
    1. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S. et al.SYNERGY trial investigators. Enoxaparin versus unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004;14:45–54.
    1. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;14:774–782. doi: 10.1161/CIRCULATIONAHA.106.612812.
    1. Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schomig A. et al.Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions. Appropriateness of including bleeding as a component of a quadruple endpoint. J Am Coll Cardiol. 2008;14:690–697. doi: 10.1016/j.jacc.2007.10.040.
    1. Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F. et al.Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005;14:1200–1206. doi: 10.1016/j.amjcard.2005.06.056.
    1. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW. et al.ACUITY investigators. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;14:2203–2216. doi: 10.1056/NEJMoa062437.
    1. Pocock SJ, Mehran R, Clayton TC, Nikolsky E, Parise H, Fahy M. et al.Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications. Assessment from the acute catheterization and urgent intervention triage strategy trial. Circulation. 2010;14:43–51. doi: 10.1161/CIRCULATIONAHA.109.878017.
    1. Kadakia MB, Desai NR, Alexander KP, Chen AY, Foody JM, Cannon CP. et al.Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION registry-GWTG (national cardiovascular data registry acute coronary treatment and intervention outcomes network registry get with the guidelines) J Am Coll Cardiol Interv. 2010;14:1166–1177. doi: 10.1016/j.jcin.2010.08.015.
    1. Moscucci M, Fox KA, Cannon CP, Klein W, López-Sendón J, Montalescot G. et al.Predictors of major bleeding in acute coronary syndromes: the global registry of acute coronary events (GRACE) Eur Heart J. 2003;14:1815–1823. doi: 10.1016/S0195-668X(03)00485-8.
    1. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol. 1953;14:368–376. doi: 10.3109/00016925309136722.
    1. Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand JP. et al.Improving clinical outcomes by reducing bleeding in patients with non-ST segment elevation acute coronary syndromes. Eur Heart J. 2009;14:655–661.
    1. Verheugt FWA, Steinhubl SR, Hamon M, Darius H, Steg PG, Valgimigli M. et al.Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. J Am Coll Cardiol Intv. 2011;14:191–197. doi: 10.1016/j.jcin.2010.10.011.
    1. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn. 1989;14:3–7. doi: 10.1002/ccd.1810160103.
    1. Kiemeneij F, Laarman GJ. Percutaneous transradial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn. 1993;14:173–178. doi: 10.1002/ccd.1810300220.
    1. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, Rigattieri S, Turri M, Anselmi M. et al.Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;14:349–356. doi: 10.1016/j.jacc.2004.04.034.
    1. Jolly S, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P. et al.Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomized, parallel group, multicenter trial. Lancet. 2011;14:1409–1420. doi: 10.1016/S0140-6736(11)60404-2.
    1. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D. et al.Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010;14:254–263. doi: 10.1016/j.jacc.2010.05.008.
    1. Roy P, Bonello L, Torguson R, de Labriolle A, Lemesle G, Slottow TL. et al.Impact of nuisance bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol. 2008;14:1614–1617. doi: 10.1016/j.amjcard.2008.07.063.
    1. Fitts J, Ver LP, Hofmaster P, Malenka D. Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications. J Interv Cardiol. 2008;14:273–278. doi: 10.1111/j.1540-8183.2008.00351.x.
    1. Seto AH, Abu-Fadel MS, Sparling JM, Zacharias SJ, Daly TS, Harrison AT. et al.Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (femoral arterial access with ultrasound trial) J Am Coll Cardiol Intv. 2010;14:751–758. doi: 10.1016/j.jcin.2010.04.015.
    1. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med. 2006;14:1464–1476.
    1. Patel MR, Jneid H, Derdeyn CP, Klein LW, Levine GN, Lookstein RA. et al.Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation. 2010;14:1882–1893. doi: 10.1161/CIR.0b013e3181f9b345.
    1. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;14:350–357. doi: 10.1001/jama.291.3.350.
    1. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z. et al.Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;14:1200–1209.
    1. Vaitkus PT. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol. 2004;14:243–246.
    1. Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J. 2007;14:606–611. doi: 10.1016/j.ahj.2006.12.014.
    1. Sanborn TA, Ebrahimi R, Manoukian SV, McLaurin BT, Cox DA, Feit F. et al.Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Circ Cardiovasc Interv. 2010;14:57–62. doi: 10.1161/CIRCINTERVENTIONS.109.896704.
    1. Mehran R, Rao SV, Bhatt DL, Gibson CM. et al.Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;14:2736–2747. doi: 10.1161/CIRCULATIONAHA.110.009449.
    1. Andrade MVA, Andrade PB, Barbosa RA, Tebet MA, Silva FSM, Labrunie A. et al.Validação de protocolo para obtenção de hemostasia com dispositivo de compressão radial TR Band™ após intervenção coronária percutânea. RBCI. 2011;14:184–188.
    1. Rathore S, Stables RH, Pauriah M, Hakeem A, Mills JD, Palmer ND. et al.A randomized comparison of TR band and RadiStop hemostatic compression devices after transradial coronary intervention. Catheter Cardiovasc Interv. 2010;14:660–667. doi: 10.1002/ccd.22615.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner